Amgen Inc.
ANTI-TNF ALPHA ANTIBODY FORMULATIONS
Last updated:
Abstract:
Stable adalimumab formulations are disclosed.
Status:
Application
Type:
Utility
Filling date:
20 Dec 2017
Issue date:
19 Mar 2020